1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined single cell atlasing and organoid modeling reveal progressive plasticity during human colorectal cancer metastasis
    Meeting Abstract

    Ganesh, K.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Chan, S. L.; Kudo, M.; Sangro, B.; Kelley, R. K.; Furuse, J.; Park, J. W.; Sunpaweravong, P.; Fasolo, A.; Yau, T.; Kawaoka, T.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase III HIMALAYA study
    Meeting Abstract

    Vogel, A.; Chan, S. L.; Furuse, J.; Tak, W. Y.; Masi, G.; Varela, M.; Kim, J. H.; Tanasanvimon, S.; Reig Monzon, M. E.; Dayyani, F.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Chan, S. L.; Kudo, M.; Sangro, B.; Kelley, R. K.; Furuse, J.; Park, J. W.; Sunpaweravong, P.; Fasolo, A.; Yau, T.; Kawaoka, T.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
    Meeting Abstract

    Kuboki, Y.; Yaeger, R.; Fakih, M.; Strickler, J. H.; Masuishi, T.; Kim, E. J. H.; Bestvina, C. M.; Langer, C. J.; Krauss, J. C.; Puri, S.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma- A case report
    Journal Article

    El Dika, I.; Shia, J.; Chen, C. L.; Paroder, V.; Carver, A.; Shamseddine, A.; Mukherji, D.; Sirohi, B.; Makondi, P. T.; Asseily, C.; more...
    Journal of Gastrointestinal Oncology (2022)

    Fulltext@MSK | Save
  • Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
    Review

    de Castria, T. B.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Shifting the focus of zebrafish toward a model of the tumor microenvironment
    Review

    Weiss, J. M.; Lumaquin-Yin, D.; Montal, E.; Suresh, S.; Leonhardt, C. S.; White, R. M.
    eLife (2022)

    Fulltext@MSK | Save
  • Extended overall survival results from the POLO study of active maintenance olaparib in patients with metastatic pancreatic cancer and a germline BRCA mutation
    Meeting Abstract

    Arnold, D.; Hammel, P.; Golan, T.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - A randomized, double-blind, placebo-controlled, phase 3 study
    Meeting Abstract

    Janjigian, Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Evans, B.; Ruscica, D.; Robbins, S. H.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save